Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific Antibodies Convoca: Pfizer, Inc Termini: 08/05/2026
Path to a Cure Academic Programs Convoca: Cystric Fibrosis Foundation Termini: 12/05/2026
Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate‑to‑Severe Atopic Dermatitis Convoca: Pfizer Inc Termini: 13/05/2026
CRIS Excellence Programme Convoca: Fundación CRIS de investigación contra el cáncer Termini: 13/05/2026
PMF–ALZ AD/ADRD Fellows Program Convoca: Pascual Maragall Foundation Termini: 13/05/2026 Translational and clinical research on AD/ADRD
Diagnosis and Treatment of Cancer Cachexia Convoca: Pfizer, Inc Termini: 14/05/2026